ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990

Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program

June 4, 1999

Funding Opportunities

January 10, 2003

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

March 9, 1990